JP Morgan Chase’s BrightSpring Health Services BTSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.1M Buy
241,297
+31,474
+15% +$1.75M ﹤0.01% 2350
2026
Q1
$8.72M Buy
209,823
+26,142
+14% +$1.05M ﹤0.01% 2810
2025
Q4
$6.88M Sell
183,681
-115,069
-39% -$3.86M ﹤0.01% 3031
2025
Q3
$8.83M Buy
298,750
+42,603
+17% +$990K ﹤0.01% 2830
2025
Q2
$6.04M Sell
256,147
-240,038
-48% -$5.01M ﹤0.01% 2982
2025
Q1
$8.98M Buy
496,185
+451,820
+1,018% +$8.87M ﹤0.01% 2636
2024
Q4
$756K Sell
44,365
-119,253
-73% -$2.06M ﹤0.01% 4809
2024
Q3
$2.4M Buy
163,618
+120,005
+275% +$1.5M ﹤0.01% 3859
2024
Q2
$495K Buy
43,613
+22,330
+105% +$244K ﹤0.01% 4693
2024
Q1
$231K Buy
+21,283
New +$213K ﹤0.01% 5271

Other funds holding BTSG

JP Morgan Chase's BTSG Position: Q2 2026 in Review

JP Morgan Chase increased its BrightSpring Health Services (BTSG) stake by 15% in Q2 2026, buying an estimated $1.75M and bringing the position to 241,297 shares worth $17.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2350.

JP Morgan Chase first reported a position in BTSG in Q1 2024 and has held it in 10 quarters since. 423 funds tracked by Wall St. Rank hold BTSG as of Q2 2026.

  • JP Morgan Chase held 241,297 shares of BrightSpring Health Services worth $17.1M as of Q2 2026.
  • JP Morgan Chase bought 31,474 BrightSpring Health Services shares in Q2 2026, an estimated $1.75M.
  • BrightSpring Health Services made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #2350 holding.
  • JP Morgan Chase first reported a position in BrightSpring Health Services in Q1 2024 and has held it in 10 quarters since.
  • 423 funds tracked by Wall St. Rank held BrightSpring Health Services as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.